Key result
Novel Stent D matches Solitaire FR with a ~96% in vitro thrombus retrieval rate.
Why the study?
Does a novel stent retriever design (Stent D) improve mechanical properties and thrombus retrieval compared to commercial stents in in vitro acute ischemic stroke models?
Does a novel stent retriever design (Stent D) improve mechanical properties and thrombus retrieval compared to commercial stents in in vitro acute ischemic stroke models?
Absolute Event Rate: 95.51% vs 96.16%
No takes yet. Share an insight, caveat, or question.
A novel stent retriever design (Stent D) demonstrated comparable mechanical properties and thrombus retrieval efficacy to commercial stents in in vitro testing, suggesting potential for clinical evaluation.
Lee et al. (2024) studied Acute ischemic stroke. Stent D vs. Solitaire FR and Trevo XP ProVue was evaluated on Thrombus retrieval rate. In vitro testing demonstrated that the novel Stent D achieved a 95.51% thrombus retrieval rate, performing comparably to the commercial Solitaire FR stent (96.16%).
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: